Halozyme, Inc. · 2 weeks ago
Vice President, Corporate Development (Mergers and Acquisitions)
San Diego, CA
Full-time
Onsite
Director/Executive
$264K/yr - $387K/yr
15+ years expHalozyme, Inc. is dedicated to reinventing the patient experience and innovating drug delivery. The Vice President, Corporate Development will inform and execute the company’s M&A growth strategy, overseeing strategic transactions including acquisitions and collaborations while collaborating with various internal groups to analyze new opportunities.
BiotechnologyMarketingMedical
Responsibilities
Develop and drive corporate M&A strategy
Works independently and in collaboration with internal groups to provide detailed economic analyses of new opportunities (e.g., market research, business intelligence, competitive analysis, development plan, commercial forecast, NPV analyses) to inform business decisions
Presents business rationale, analyses, and proposals to senior executives
Coordinates the evaluation and diligence of new opportunities endorsed by the Strategic Investment Counsel across multiple functional areas including Research, Clinical, Regulatory, Commercial, Manufacturing, Finance, Legal, Intellectual Property and other groups
Develops deal concepts and negotiates term sheets, deal structure, and definitive agreements in collaboration with corporate legal and finance groups
Drives the deal process from first contact with potential partners to execution of agreements
Establishes an extensive network of strong and trusting relationships with prospective targets, advisors, and industry investors with the goal of expanding the external perception of Halozyme as a partner of choice
Qualification
Required
Minimum of Advanced degree in Life Sciences or MBA with minimum of 15 years of relevant experience in biotech or pharmaceutical industry (An equivalent combination of experience and education may be considered)
Proven track record of accomplishing Corporate Development goal objectives through deal sourcing, due diligence, licensing, and M&A execution
Extensive in-pharma Corporate Development experience
Strong analytical and financial acumen
Deep understanding of drug or product development, regulatory pathways, and commercial strategy to evaluate opportunities beyond financial analysis
Experienced leadership in managing cross-functional teams across R&D, legal, finance, and commercial functions
Proven experience identifying, leading, and executing a minimum of three end-to-end M&A transactions totaling approximately $1–2 billion in aggregate valuation over 2–3 years
Benefits
Employee Stock Purchase Program
401(k) matching
Opportunities to grow in a culture that prioritizes learning, development and progression through in-house programs and tuition reimbursement
Company
Halozyme, Inc.
Halozyme is a biopharmaceutical company bringing disruptive solutions to significantly improve patient experiences and outcomes for emerging and established therapies.
201-500 employees
H1B Sponsorship
Halozyme, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (2)
2023 (2)
2022 (3)
2021 (1)
Funding
Current Stage
Public CompanyTotal Funding
$2.75BKey Investors
Janssen Biotechargenx
2025-11-06Post Ipo Debt· $1.3B
2022-08-15Post Ipo Debt· $500M
2021-02-24Post Ipo Debt· $700M
Leadership Team
Helen Torley
President and Chief Executive Officer
Cortney Caudill
Chief Operating Officer
Recent News
Longevity.Technology
2026-01-07
Company data provided by crunchbase